• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren

byConstance WuandAliya Ramjaun
May 16, 2019
in Chronic Disease, Ophthalmology, Pediatrics, Public Health
Reading Time: 2 mins read
Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren
Share on FacebookShare on TwitterShare on LinkedIn

Children in many developing countries have poor vision. In China, poor vision accounts for nearly half of all childhood disability. China has been experiencing unprecedented economic growth over the last several decades, however, this does not necessarily translate into improvement across all domains of health. In this retrospective cohort study, investigators analyzed data from 1,951,084 children in China from 1995 to 2014 in order to examine trends in visual impairment and identify any association with economic factors. The GDP in China increased from $1263 to $7594 over the time period studied. Investigators found that after adjusting for multiple demographic characteristics, every 100% increase in GDP from 1995 to 2014 was associated with a 20% increase in the prevalence ratio of visual impairment (VI) (PR 1.20, 95% CI 1.20 to 1.21). This association between GDP increase and VI was stronger in males (PR 1.22 for males, 95% CI 1.21 to 1.23, vs. PR 1.19, 95% CI 1.18 to 1.19 for female, p<0.001). Rural areas and younger age groups were also increasingly affected during the time period studied. Geographically, more economically developed regions had higher prevalence of VI for all survey years. The results from this study suggest that China’s economic development is associated with the increase in VI in children, which has implications for global health practices and policies as China and other countries continue to develop. This study, however, is limited in that it was cross-sectional nature; the results do not establish a causal relationship.

Click to read the study in JAMA Pediatrics

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Tenecteplase not associated with visual improvement in central retinal artery occlusion

Aurion Biotech: Cell Therapy AURN001 Improves Vision in Patients with Corneal Endothelial Disease

Tags: chinaeconomic growthvisual acuityvisual impairment
Previous Post

#VisualAbstract: Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

Next Post

Quick Take: Glucagon Receptor Antagonist–Stimulated α-Cell Proliferation Is Severely Restricted With Advanced Age

RelatedReports

siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Neurology

Tenecteplase not associated with visual improvement in central retinal artery occlusion

January 28, 2026
Adalimumab aids in control of noninfectious uveitis
Pharma

Aurion Biotech: Cell Therapy AURN001 Improves Vision in Patients with Corneal Endothelial Disease

January 31, 2025
#VisualAbstract Adverse Social Determinants of Health are Associated with More Severe Rhegmatogenous Retinal Detachment
StudyGraphics

#VisualAbstract Adverse Social Determinants of Health are Associated with More Severe Rhegmatogenous Retinal Detachment

August 27, 2024
#VisualAbstract: Low-Dose Daily Aspirin does not Affect the Progression of Age-Related Macular Degeneration
StudyGraphics

#VisualAbstract: Low-Dose Daily Aspirin does not Affect the Progression of Age-Related Macular Degeneration

June 14, 2024
Next Post

Quick Take: Glucagon Receptor Antagonist–Stimulated α-Cell Proliferation Is Severely Restricted With Advanced Age

Use of aspirin for primary prevention linked to increased risk of intracranial hemorrhage

Use of aspirin for primary prevention linked to increased risk of intracranial hemorrhage

Shared decision-making tool for antidepressants improves patient and physician satisfaction

Quick Take: Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.